(Total Views: 214)
Posted On: 04/01/2019 8:05:07 AM
Post# of 149272
What do you think of this senstence from the PR? Does this mean they started enrollment and will inject the first patient soon?
“CytoDyn has now opened a clinical trial (NCT03838367) that is assessing the efficacy of leronlimab (PRO 140) in metastatic triple negative breast cancer and will measure CTCs in the enrolled patients.”
“CytoDyn has now opened a clinical trial (NCT03838367) that is assessing the efficacy of leronlimab (PRO 140) in metastatic triple negative breast cancer and will measure CTCs in the enrolled patients.”
(0)
(0)Scroll down for more posts ▼
